Comprehensive understanding of a rare disease: Cardiac metastatic tumor, a double-center 10-year case review

doi:10.4330/wjc.v17.i2.101851

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-3)

Sum=0

Feb 26, 2025 (publication date) through Feb 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Cardiol. Feb 26, 2025; 17(2): 101851
Published online Feb 26, 2025. doi: 10.4330/wjc.v17.i2.101851

Table 2 Baseline characteristics of pericardial and intracardiac metastasis groups

	All (n = 226)	Pericardial metastasis (n = 161)	Intracardiac metastasis (n = 65)	P value
Age (year)	58.89 ± 12.86	60.01 ± 12.51	56.14 ± 13.40	0.040
Male	152 (67.26)	107 (66.46)	45 (69.23)	0.687
BMI (kg/m²)	22.56 ± 3.00	22.45 ± 2.97	22.96 ± 3.14	0.380
Basic vital signs
RR	20.00 (20.00, 20.00)	20.00 (20.00, 20.00)	20.00 (19.50, 20.00)	0.038
HR	80.50 (78.00, 96.00)	81.00 (78.00, 96.00)	80.00 (78.00, 95.00)	0.683
SBP (mmHg)	120.00 (110.00, 130.00)	120.00 (110.00, 130.00)	120.00 (112.00, 126.00)	0.775
DBP (mmHg)	76.00 (70.00, 82.00)	76.00 (69.00, 81.00)	78.00 (70.00, 85.00)	0.175
Temperature (°C)	36.50 (36.40, 36.60)	36.50 (36.40, 36.60)	36.50 (36.40, 36.60)	0.981
SpO₂	99.00 (99.00, 99.00)	99.00 (99.00, 99.00)	99.00 (99.00, 99.00)	0.975
Past history
Smoking	88 (38.94%)	71 (44.10%)	17 (26.15%)	0.010
Drinking	51 (22.57%)	45 (27.95%)	6 (9.23%)	0.001
Diabetes	13 (5.75%)	11 (6.83%)	2 (3.08%)	0.245
Hyperlipidemia	10 (4.42%)	9 (5.59%)	1 (1.54%)	0.140
Hypertension	46 (20.35%)	33 (20.55%)	13 (20.00%)	0.933
Clinical indicators
EF (%)	66.00 (63.00, 69.00)	66.00 (62.00, 69.00)	67.00 (63.00, 71.00)	0.183
D-Dimer (mg/L)	1.06 (0.40, 2.95)	0.84 (0.31, 2.36)	2.16 (1.00, 3.67)	< 0.001
PT (second)	13.30 (12.20, 14.30)	13.00 (12.00, 14.00)	13.90 (12.95, 15.10)	< 0.001
Fibrinogen (g/L)	3.79 (2.65, 4.98)	3.70 (1.83, 4.83)	4.15 (3.23, 5.53)	0.003
INR	1.11 (1.03, 1.35)	1.11 (1.04, 2.20)	1.10 (1.03, 1.22)	0.203
BNP (pg/mL)	137.50 (56.00, 456.00)	120.00 (54.00, 292.00)	324.00 (110.00, 903.00)	0.001
Troponin (ug/L)	1.00 (0.010, 7.75)	0.022 (0.0060, 4.40)	5.35 (2.43, 36.08)	< 0.001
Treatment
Operation	104 (46.02%)	73 (45.34%)	31 (47.69%)	< 0.001

For pericardial metastasis, the main operations are pericardiocentesis drainage and affected pericardium resection. For cardiac metastasis, it is the resection of affected parts. BMI: Body mass index; RR: Respiratory rate; HR: Heart rate; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; SpO₂: Percutaneous arterial oxygen saturation; EF: Ejection fraction; PT: Prothrombin time; INR: International standardized ratio; BNP: Brain natriuretic peptide.

Citation: Luo LY, Yang TS, He Z, Lin L, Luo XL. Comprehensive understanding of a rare disease: Cardiac metastatic tumor, a double-center 10-year case review. World J Cardiol 2025; 17(2): 101851
URL: https://www.wjgnet.com/1949-8462/full/v17/i2/101851.htm
DOI: https://dx.doi.org/10.4330/wjc.v17.i2.101851